Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Public ClinicalTrials.gov record NCT07441694. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Open-Label, Multicenter Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Study identification
- NCT ID
- NCT07441694
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Incyte Corporation
- Industry
- Enrollment
- 218 participants
Conditions and interventions
Conditions
Interventions
- INCA036978 Drug
- Standard disease-directed therapy Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 10, 2026
- Primary completion
- May 23, 2030
- Completion
- May 23, 2030
- Last update posted
- Jul 21, 2026
2026 – 2030
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama At Birmingham | Birmingham | Alabama | 35233 | Not yet recruiting |
| City of Hope-Lennar Foundation Cancer Center | Irvine | California | 92618 | Not yet recruiting |
| Usc Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | Not yet recruiting |
| UCLA Medical Hematology & Oncology | Los Angeles | California | 90095 | Not yet recruiting |
| Yale Cancer Center | New Haven | Connecticut | 06510 | Not yet recruiting |
| University of Miami | Miami | Florida | 33136 | Not yet recruiting |
| Moffitt Cancer Center | Tampa | Florida | 33612 | Not yet recruiting |
| Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | Recruiting |
| John Hopkins Hospital | Baltimore | Maryland | 21287 | Not yet recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Not yet recruiting |
| Washington University School of Medicine | St Louis | Missouri | 63108 | Not yet recruiting |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10021 | Not yet recruiting |
| Mount Sinai School of Medicine | New York | New York | 10029 | Not yet recruiting |
| Weill Cornell Medicine | New York | New York | 10065 | Not yet recruiting |
| University of North Carolina At Chapel Hill | Chapel Hill | North Carolina | 27514 | Not yet recruiting |
| Levine Cancer Institute | Charlotte | North Carolina | 28204 | Not yet recruiting |
| Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy | Durham | North Carolina | 27705 | Not yet recruiting |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Not yet recruiting |
| Ohio State University | Columbus | Ohio | 43210 | Recruiting |
| Tristar Bmt/Tcto | Nashville | Tennessee | 37203 | Recruiting |
| University of Texas M. D. Anderson Cancer Center | Houston | Texas | 77030 | Not yet recruiting |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | Not yet recruiting |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07441694, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 21, 2026 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07441694 live on ClinicalTrials.gov.